The American Society of Nuclear Cardiology (ASNC) is alerting its provider members of a pyrophosphate shortage, which could potentially last for weeks.
The ASNC has received reports of imaging agent 99mTechnetium-pyrophosphate (PYP) being in low supply, citing statements it received from two manufacturers, Curium and Sun Radiopharma, who blame the shortage on supply chain disruptions.
According to the ASNC, Curium said it is working to find an alternative supplier to resume normal production as soon as possible. In its own statement, Sun Radiopharma provided a “best estimate” of January 2024 for PYP production to resume as normal.
The company also lists shortages in other radiopharmaceutical products, with estimates for when supplies will be available. The full statement from Sun Radiopharma can be found here.
Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.